Chattem, Inc. announced that on November 30, 2005 the Company sold its pHisoderm line of skin care products to The Mentholatum Company, Inc. for $8.5 million plus inventories of approximately $1.1 million. Sales of the pHisoderm line represented approximately 4% and 5% of net sales in fiscal 2005 and 2004, respectively. “The sale of pHisoderm to a strategic buyer enables us to redirect our core competencies into the continued growth of our leading brands,” said Zan Guerry, the Chat...